Cannabis sativa phytoligands as potential EGFR inhibitors for lung cancer treatment.

Owoloye A, Akinnusi PA, Olubode SO, Adu EA, Shakela N, Oyerinde DO, Onawola OL, Oyebola KM

Open source

DOI
10.21203/rs.3.rs-11024152/v1
Published
2026 Oct 13
Container
Research square
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21203/rs.3.rs-11024152/v1,
  title = {Cannabis sativa phytoligands as potential EGFR inhibitors for lung cancer treatment.},
  author = {Owoloye A and Akinnusi PA and Olubode SO and Adu EA and Shakela N and Oyerinde DO and Onawola OL and Oyebola KM},
  year = {2026},
  journal = {Research square},
  doi = {10.21203/rs.3.rs-11024152/v1},
  url = {https://doi.org/10.21203/rs.3.rs-11024152/v1}
}

RIS

TY  - JOUR
TI  - Cannabis sativa phytoligands as potential EGFR inhibitors for lung cancer treatment.
AU  - Owoloye A
AU  - Akinnusi PA
AU  - Olubode SO
AU  - Adu EA
AU  - Shakela N
AU  - Oyerinde DO
AU  - Onawola OL
AU  - Oyebola KM
PY  - 2026
JO  - Research square
DO  - 10.21203/rs.3.rs-11024152/v1
UR  - https://doi.org/10.21203/rs.3.rs-11024152/v1
ER  - 

APA

A, O., PA, A., SO, O., EA, A., N, S., DO, O., OL, O., & KM, O. (2026). Cannabis sativa phytoligands as potential EGFR inhibitors for lung cancer treatment.. Research square. https://doi.org/10.21203/rs.3.rs-11024152/v1

Source records